New & Exciting at TUC
News items updated 05/4/2019
Photobiomodulation is coming to TUC. The newest therapy for pelvic floor pain will soon be offered at The Urogynecology Center. We will begin treating patients on June 21, 2019. We will be the first office involved in a multi-center trial using this new therapy for chronic myofascial pain. This is extremely exciting and will likely change how we manage chronic pelvic pain.
- Dr. B. did a round table discussion “meet the experts“ at the 2015 annual AUGS meeting on the management of mesh complications.
- Dr. B. was asked to do an entire workshop on the management of transvaginal mesh related complications at the combined meetings of AUGS and the International Continence Society in 2014.
- Dr. B. presented his data concerning the use of intraoperative neurodiagnostics during the placement of InterStim. His success rate in the last 10 years of 94% amazed many of the attendees at the annual Society of urodynamics and female urology meeting in 2016
- Dr. B. has been asked to be the key speaker at the Seattle gynecologic Society in September 2016. He has been asked to discuss topics to include chronic pelvic pain, persistent postoperative pain and painful bladder syndrome/interstitial cystitis.
- Dr. B. has been asked to do to round table discussions “meet the experts” for the upcoming 2016 annual AUGS meeting. The topics he has been asked to discuss includes neurodiagnostic testing during the placement of InterStim and persistence of postoperative pain-identification and prevention.
- Dr. B. has had his article concerning persistent postoperative pain published in the Journal of Female Pelvic Medicine and Reconstructive Surgery. It was so well received they are planning on a podcast so that this ground breaking information can be more widely disseminated. Click here to read the article!
- TUC is involved in two research studies for the management of various types of pelvic pain. 1 involves the treatment of interstitial cystitis and the other involves a new therapeutic option for pelvic floor myofascial pain disorders.